Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.
Biochemistry. 2010 Feb 9;49(5):951-7. doi: 10.1021/bi9017335.
par3 is a multiple-PDZ-containing scaffold protein that is central to the organization of an evolutionarily conserved cell polarity complex consisting of par3, par6, and aPKC. The ability of par3 PDZ domains to target various adhesion molecules and enzymes at the plasma membrane leads to the controlled localization of par6 and aPKC, which has firmly established its role in epithelial cell polarity. Of the numerous PDZ ligands associated with par3, interaction of its third PDZ domain with the class II ligand found within the C-terminal tail of vascular endothelial cadherin (VE-Cad) suggests a role in endothelial cell polarity as well, but the molecular details of the interaction are unknown. Previously determined structures of par3-PDZ3 bound to the class I ligand found within the C-terminal tail of the phosphoinositide phosphatase PTEN revealed two discrete binding sites: a canonical PDZ-ligand interaction site and a distal site involving charge-charge complements. Currently, it is unclear if par3-PDZ3 employs both canonical and distal binding modes in its association with VE-Cad or if these modes are unique to the PTEN interaction, suggesting a possible mechanism for ligand specificity within the polarity network. The structure of par3-PDZ3 bound to the C-terminal tail of VE-Cad presented in this work shows that both canonical and distal interactions are utilized in binding. Biophysical measurements using fluorescence polarization and two-dimensional NMR implicate the intermolecular charge pairing of aspartic acid 777 (VE-Cad) and arginine 609 (par3-PDZ3) as a crucial modulator of complex formation. Phosphorylation of VE-Cad at serine 776 increases its affinity for par3, demonstrating that post-translational modifications outside of the canonical carboxylate binding site can enhance PDZ-ligand interactions. Comparison of the VE-Cad and PTEN complexes highlights how the unique molecular architecture of par3-PDZ3 can accommodate both canonical and distal interaction modes that allow dual-class specificity for these two ligand types.
PAR3 是一种含有多个 PDZ 结构域的支架蛋白,是由 PAR3、PAR6 和 aPKC 组成的进化上保守的细胞极性复合物的核心。PAR3 的 PDZ 结构域能够靶向质膜上的各种粘附分子和酶,从而导致 PAR6 和 aPKC 的定位受到控制,这就牢固地确立了其在上皮细胞极性中的作用。在与 PAR3 相关的众多 PDZ 配体中,其第三个 PDZ 结构域与血管内皮钙黏蛋白(VE-Cad)的 C 端尾部内发现的 II 类配体的相互作用表明它在血管内皮细胞极性中也有作用,但相互作用的分子细节尚不清楚。以前确定的 PAR3-PDZ3 与 PTEN 的 C 端尾部内发现的 I 类配体结合的结构揭示了两个离散的结合位点:一个是典型的 PDZ-配体相互作用位点,另一个是涉及电荷互补的远侧位点。目前尚不清楚 PAR3-PDZ3 在与 VE-Cad 结合时是否同时采用典型和远侧结合模式,或者这些模式是否仅适用于 PTEN 相互作用,这表明在极性网络中存在配体特异性的可能机制。本文介绍的 PAR3-PDZ3 与 VE-Cad 的 C 端尾部结合的结构表明,两种结合模式都被利用了。荧光偏振和二维 NMR 的生物物理测量表明,天冬氨酸 777(VE-Cad)和精氨酸 609(PAR3-PDZ3)之间的分子间电荷配对是复合物形成的关键调节剂。VE-Cad 的丝氨酸 776 磷酸化增加了其与 PAR3 的亲和力,表明在典型的羧酸盐结合位点之外的翻译后修饰可以增强 PDZ-配体相互作用。VE-Cad 和 PTEN 复合物的比较突出了 PAR3-PDZ3 的独特分子结构如何能够容纳典型和远侧相互作用模式,从而为这两种配体类型提供双重的类特异性。